Insiders / Coloma Jason V

Coloma Jason V

CIK 1676170personinsider

Companies

First seen

Mar 3, 2026

Last activity

Mar 3, 2026

Companies

Company	Role	Shares held	Peak held	Trades	Latest
Maze Therapeutics, Inc. · MAZE	CEO	—	150,000	2	—

2 positions · latest reported per filing

Company	Security	Shares	As of
Maze Therapeutics, Inc.	Stock Option (Right to Buy)Derivative	150,000	Mar 2, 2026
Maze Therapeutics, Inc.	Restricted Stock UnitsDerivative	75,000	Mar 2, 2026

InsidersInstitutions

This person's insider trades (Form 4), across every company.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Mar 2, 2026	Grant	MAZE Maze Therapeutics, Inc. Restricted Stock Units	—	+75K	75,000 0.14% of shares	low
Mar 2, 2026	Grant	MAZE Maze Therapeutics, Inc. Stock Option (Right to Buy)	—	+150K	150,000 0.27% of shares	low